According to the study of Metzger et al. (17), carried out on gastric cancers, the expression of ERCC1 and of TS in the tumor are two independent variables, correlated with the clinical response to chemotherapy combining 5-FU and cisplatin. Here, ERCC1 is linked to gastric cancer.